This site is intended for healthcare professionals

Lilly's OVERCOME study reveals nearly 80% of people reported improvement in their migraine since starting a CGRP monoclonal antibody for preventive treatment.

Read time: 2 mins
Last updated:10th Oct 2020
Published:10th Oct 2020
Condition: Migraine/Headache
Type: drug
Register free for full access to